Key result
The recently published European guidelines for percutaneous coronary interventions are criticized for unbalanced statements, reliance on unavailable stents, and neglecting relevant RCT results.
Answers are grounded in this paper and cite their sources.
This editorial highlights perceived flaws and unbalanced statements in the European guidelines for percutaneous coronary interventions, calling for an update.
The recently published guidelines for PCI1 by the European task force were set out to mark a timely milestone, but missed this goal unfortunately as a result of unbalanced statements. Various peculiarities make it difficult to follow those guidelines for various reasons. First, statements and findings from the Taxus VI trial were utilized for the paper,2 although the stent utilized in Taxus VI has never been marketed and is not available while results from other trials are neglected. Secondly, results from RCTs on various interesting subsets of patients with focus on in-stent restenosis, diabetes, and small vessels have not been taken into consideration; nevertheless, the authors of the guidelines are demanding such RCTs even at a time when ARTS II and TROPICAL could not use bare metal controls, but rather had to compare with historical controls for ethical reason.3,4 Thirdly, the authors' conclusion of equipotential effects of sirolimus and paclitaxel coated stents only on the basis on the small TAXI trial is likely to be oversimplified and more than courageous5; justified is only that the hypothesis of 6% MACE with sirolimus and 14% with paclitaxel were not met. Finally, although the preamble to those guidelines claims both to present all relevant evidence on a particular issue and to be developed by an unquestionable decision-making process, none of those standards have been met. It is already late for an update.
No takes yet. Share an insight, caveat, or question.
C. A. Nienaber (2006) conducted a letter in Percutaneous coronary interventions. The recently published European guidelines for percutaneous coronary interventions are criticized for unbalanced statements, reliance on unavailable stents, and neglecting relevant RCT results.
Synapse has enriched 10 related papers. Consider them for comparative context: